Abstract
BackgroundTriple negative breast cancer (TNBC) is a subtype of breast cancers with poor prognosis and targeted drug therapies are limited. To develop novel and efficacious therapies for TNBC, we developed...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have